The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
ProteinQure
Old Toronto, Canada
A
11-50 Employees
2017
Key takeaway
ProteinQure focuses on the computational design of novel peptides and other protein-based therapeutics, utilizing artificial intelligence and physics-based methods to create drug-like peptides with therapeutic applications. Their advanced platform, ProteinStudio, enables the design of innovative peptides that can effectively deliver therapeutic payloads, highlighting the advantages of peptides for targeted drug delivery.
Highlighted product
Core business
ProteinQure
Computational protein drug design.
Designed Biologics
Ottawa, Canada
A
- Employees
-
Key takeaway
Designed Biologics specializes in developing small peptides with tailored targeting properties, utilizing a computational platform that enhances the design of specific antibodies for therapeutic applications. Their innovative approach, powered by AI, focuses on creating peptides that effectively address various protein targets.
Highlighted product
Core business
DesignedBiologics - Designing the future of medicine
We use AI to design peptides with custom targeting properties for therapeutics
Precision Proteomics
Old Toronto, Canada
A
1-10 Employees
-
Key takeaway
Precision Proteomics Inc (PPI) focuses on advancing precision medicine research through innovative proteomics technologies, particularly in the systematic characterization of protein kinases and phosphorylation. Their expertise in phosphoproteomics supports biomarker discovery and drug development for pharmaceutical and biotechnology companies.
Highlighted product
Core business
Precision Medicine Research and Development Biomedical
PrecisionProteomics (PPI) is a biotechnology company commercializing a precision medicine research for basic, pre-clinical and clinical applications
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Proteic Bioscience
Vancouver, Canada
A
11-50 Employees
-
Key takeaway
PROTEIC focuses on creating predictive disease models by leveraging advanced AI technology and insights from genetic and clinical data. Their approach enhances traditional analyses, potentially advancing the development of peptide therapeutics by uncovering causal biology related to diseases.
Highlighted product
Product
Technology – Proteic Bioscience Inc.
Interface Biologics, Inc.
Old Toronto, Canada
A
11-50 Employees
2001
Key takeaway
Ripple Therapeutics is focused on developing peptide therapeutics through its innovative Epidel™ technology, which enables the creation of controlled-release prodrug implants without the use of polymers or excipients. Their lead product is a fully degradable intravitreal dexamethasone prodrug implant, targeting conditions like diabetic macular edema and retinal vein occlusion.
Highlighted product
Core business
Ripple Therapeutics
The Ripple Therapeutics' Epidel technology is founded on a discovery that drugs can be engineered into controlled release Pharmaceuticals and Medical Device Coatings without the use of polymers or excipients. Our lead product (IBE-814 IVT) is a fully degradable intravitreal dexamethasone prodrug implant targeting DME, RVO and NIU indications.
Treventis
Old Toronto, Canada
A
11-50 Employees
2008
Key takeaway
TREVENTIS™ Corporation employs a patented discovery engine, Common Conformational Morphology (CCM), to pinpoint druggable active sites in misfolded proteins, which is highly relevant for peptide therapeutics. Their focus on small molecule inhibitors of tau and beta-amyloid oligomerization positions them at the forefront of addressing neurodegenerative diseases.
Highlighted product
Product
Technology - TREVENTIS™ Corporation
Because amyloid proteins fold into various conformations and are generally disordered, it has been impossible to develop crystal structures to support rational […]
Repare Therapeutics
Montreal, Canada
A
11-50 Employees
2016
Key takeaway
Repare Therapeutics is a clinical-stage precision oncology company that is developing targeted therapies aimed at genetic alterations in tumors, with a focus on addressing high unmet medical needs in cancer treatment. Their innovative approach, based on synthetic lethality, underpins their portfolio of promising product candidates.
Highlighted product
Core business
Repare Therapeutics | Synthetic Lethality Precision Oncology
Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to developing novel medicines.
ASEP Medical
Victoria, Canada
A
11-50 Employees
2020
Key takeaway
The company specializes in peptide therapeutics, focusing on innovative technologies that demonstrate antibiofilm activity and antibiotic synergy. Their research and development efforts aim to address antibiotic-resistant infections, making significant strides in pre-clinical development.
Highlighted product
Product
Therapeutic | Asep Medical
Neoventures Biotechnology Inc
London, Canada
A
1-10 Employees
2002
Key takeaway
NeoVentures Biotechnology is a leader in aptamer development, emphasizing their potential to transform diagnostics and drug delivery. Their innovative Neomer selection method addresses current limitations in aptamer technology, which could significantly impact therapeutic approaches.
Highlighted product
Core business
NeoVentures Biotechnology: Aptamers | Neoaptamers.com
NeoVentures Biotechnology is an aptamer company that identifies & develops aptamers. We were the first to commercialize an aptamer diagnostic.
Meros Polymers
Edmonton, Canada
A
1-10 Employees
2009
Key takeaway
Meros Polymers specializes in advanced drug delivery technologies, offering innovative systems like ExCell™ and PolyGel™ for the effective delivery of small molecule drugs and RNAi to cancer cells. Their expertise in custom formulation and biocompatible, biodegradable polymers makes them a valuable resource for developing optimized delivery vehicles for peptide therapeutics and other compounds.
Highlighted product
Core business
Meros Polymers | Drug Delivery Technology | Canada
Meros Polymers Inc. is a privately held Alberta corporation formed to commercialize advanced drug delivery technologies developed within the University of Alberta Faculty of Pharmacy and Pharmaceutical Sciences.
Technologies which have been searched by others and may be interesting for you:
When exploring the Peptide Therapeutics industry in Canada, several key considerations come into play. Regulatory frameworks are crucial, as Health Canada oversees the approval and commercialization of peptide-based drugs, ensuring compliance with stringent safety and efficacy standards. Understanding the challenges related to research and development is essential, including high costs, lengthy timelines, and the complexities of peptide synthesis and formulation. Opportunities abound in Canada’s robust biotechnology sector, which is supported by a rich pool of academic research and a growing number of startups focused on innovative peptide therapies. Additionally, environmental concerns related to the production and disposal of peptide therapeutics must be addressed, as sustainability is becoming increasingly important in pharmaceutical development. The competitive landscape features both established companies and emerging players, creating a dynamic environment for innovation and collaboration. Furthermore, Canada’s position in the global market is significant, with partnerships and collaborations with international firms enhancing its relevance in peptide therapeutics. By keeping these factors in mind, individuals can gain a comprehensive understanding of the industry landscape and identify potential pathways for engagement or investment.
Some interesting numbers and facts about your company results for Peptide Therapeutics
| Country with most fitting companies | Canada |
| Amount of fitting manufacturers | 266 |
| Amount of suitable service providers | 172 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2001 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Peptide Therapeutics
What are related technologies to Peptide Therapeutics?
Based on our calculations related technologies to Peptide Therapeutics are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Peptide Therapeutics?
Start-Ups who are working in Peptide Therapeutics are ASEP Medical
Which industries are mostly working on Peptide Therapeutics?
The most represented industries which are working in Peptide Therapeutics are Biotechnology, Other, Pharmaceuticals, Medical, Healthcare
How does ensun find these Peptide Therapeutics Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
